Yunnan Botanee Bio-Technology Group Co.LTD

SZSE:300957 Stock Report

Market Cap: CN¥19.5b

Yunnan Botanee Bio-Technology GroupLTD Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhenyu Guo

Chief executive officer

CN¥5.0m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership2.6%
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Nov 02
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

Oct 19
Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Sep 25
Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

Jun 03
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

May 24
A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Feb 29
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

CEO

Zhenyu Guo (61 yo)

no data

Tenure

CN¥5,000,000

Compensation

Mr. Zhenyu Guo serves as General Manager & Non-Independent Chairman of the Board at Yunnan Botanee Bio-Technology Group Co.LTD.


Board Members

NamePositionTenureCompensationOwnership
Zhenyu Guo
GM & Non-Independent Chairman of the Boardno dataCN¥5.00m2.62%
CN¥ 511.0m
Xiao Ma
Deputy GM & Non-Independent Director2.6yrsCN¥4.00mno data
Mei Zhang
Deputy GM & Director1.6yrsCN¥2.49mno data
Kui Zhou
Non-Independent Director2.6yrsno datano data
Shaoyang Gao
Non-Independent Director2.6yrsCN¥4.00mno data
Zhiwei Li
Independent Non-Executive Director2.6yrsCN¥200.00kno data
Wei Zhou
Non-Independent Director2.6yrsCN¥600.00kno data
Ao Wang
Independent Non-Executive Director2.6yrsCN¥200.00kno data
Ning Li
Independent Non-Executive Director2.6yrsCN¥200.00kno data
Shiru Yu
Non-Employee Supervisor2.6yrsno datano data
Lei Li
Non-Employee Supervisor2.6yrsno datano data
Zurong Yang
Employee Supervisorno datano datano data

2.6yrs

Average Tenure

51yo

Average Age

Experienced Board: 300957's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 09:22
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yunnan Botanee Bio-Technology Group Co.LTD is covered by 42 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jian Jun ZouChasing Securities
Xiyue ZhangChasing Securities
Zhuonan XuChina International Capital Corporation Limited